in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (Yesterday)
Tuesday, January 26, 16 CET #SaferWorldbyDesign webinar - Cellenion will present its solutions for single-cell anal… https://t.co/VLjDHCe3VX
Edelweiss Connect (Yesterday)
RT @barryhardy: Comparison of 2D vs 3D Single Cell Transcriptomic Analyses Consider to signup for this week’s #SaferWorldbyDesign webinar…
Edelweiss Connect (2 weeks ago)
Join us for our first 2021 #webinar with #SaferWorldbyDesign partner @wepredic Prediction of the cholestatic pote… https://t.co/rXfvcHEfTT
Edelweiss Connect (2 months ago)
Join us for the upcoming #SaferWorldbyDesign webinar Validated HepaRG™ mechanistic methods as a tool for dynamic a… https://t.co/jQJSMIwWB3
Edelweiss Connect (3 months ago)
RT @barryhardy: Communicating cell culturing protocol knowledge - initial #HepaRG examples available on #saferworldbydesign https://t.co/O…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA